Doxorubicin-loaded phosphatidylethanolamine-conjugated nanoliposomes: in vitro characterization and their accumulation in liver, kidneys, and lungs in rats

Abstract

Introduction: Phosphatidylethanolamine (PE)-conjugated nanoliposomes were developed, characterized, and investigated for their accumulation in liver, kidneys, and lungs in rats. Methods: Drug-excipient interaction was studied using Fourier transform infrared spectroscopy (FTIR), differential scanning calorimetry (DSC), surface morphology by field emission scanning electron microscopy, elemental analysis by energy dispersive X-ray (EDX) analysis, zeta potential and size distribution using a Zetasizer and particle size analyzer, and in vitro drug release by dialysis membrane. In vivo accumulation of liposomes in tissues was also studied. Results: No chemical reaction was observed between drug and excipients. EDX study confirmed PE-conjugation in liposomes. Doxorubicin-loaded liposomes (DOX-L) and PE-conjugated doxorubicin-loaded liposomes (DOX-PEL) were of smooth surface and homogenously distributed in nanosize range (32-37 nm) with a negative surface charge. Loading efficiencies were 49.25% ± 1.05% and 52.98% ± 3.22% respectively, for DOX-L and DOX-PEL. In vitro drug release study showed 69.91% ± 1.05% and 77.07% ± 1.02% doxorubicin released, from DOX-L and DOX-PEL, respectively, in nine hours. Fluorescence microscopic study showed that liposomes were well distributed in liver, lungs, and kidneys. Conclusion: Data suggests that PE-conjugated nanoliposomes released the drug in a sustained manner and were capable of distributing them in various organs. This may be used for cell/ tissue targeting, attaching specific antibodies to PE.

Fabrication of novel elastosomes for boosting the transdermal delivery of diacerein: statistical optimization, ex-vivo permeation, in-vivo skin deposition and pharmacokinetic assessment compared to oral formulation

“…The DSC scan of pure DCN depicted a single endothermic peak at 256.19 °C due to its crystalline nature (Elsayed et al., 2014 ). The thermogram of CH depicted sharp endothermic transition at 146.81 °C because of degradation (Rudra et al., 2010 ). Span 60 and Brij S2 showed endothermic peaks at 55.01 and 49.88 °C, respectively, corresponding to their melting points.…”

Lipid-based nanocarrier efficiently delivers highly water soluble drug across the blood–brain barrier into brain

“…However, there were some physical interactions between the drug and excipients and between the molecules of excipients. Such physical interactions might have a role to form the spherical nanostructure of the drug carrier (Rudra et al., 2010 ) and to retain the drug in the lipid layer, causing slower diffusion of drug through the membrane (Rudra et al., 2010 ). Again, absence of peak of AZT in the lyophilized ML-based NLs was due to the entire encapsulation of AZT in the formulation.…”

“…NLs were prepared by lipid layer hydration technique by varying different process parameters (Rudra et al., 2010 ). Specific weighed amounts of excipients CHO, lipids (ML for MGF/SL for SYF, respectively) ( Supplementary Table 1 ) and BHT (1% w/v as antioxidant) were taken in 250 ml round bottom flask and adequate quantity of chloroform was added within the flask with vigorous shaking to dissolve the excipients.…”

A Novel Therapeutic Strategy for Cancer Using Phosphatidylserine Targeting Stearylamine-Bearing Cationic Liposomes

“…For the preparation of rhodamine123 or fluorescein isothiocyanate (FITC, green fluorescence) PC-SA liposome, an ethanolic solution of 1 mg/mL of rhodamine123 or FITC was added to the lipids in the respective organic solvent, followed by formation of a thin film. 27 , 51 The unentrapped fluorochromes were separated by two successive washings in PBS by ultracentrifugation (100,000 × g , 1 hr, 4°C).…”